Delivery Order SPE2DB20D2104-SPE2DB25FMFVN
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560408677 - Clindamycin Phosphate 1% Foam 50GM, with a ceiling value of $2,433.39 and a completion date of March 29, 2023. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide Clindamycin Phosphate 1% Foam in 100 gram units. The $3,572.64 contract has a completion date of February 26, 2024 and was awarded on February 23, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,393.56 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% Foam, a topical antibiotic medication. The contract has a performance period through May 31, 2023 and was awarded on May 30, 2023. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,364.86 firm fixed price contract is for the supply of Clindamycin Phosphate 1% Foam, a prescription medication, with a completion date of June 10, 2024. This order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4558478384 - Clindamycin Phosphate 1% Foam, 100 gm, with a ceiling value of $1,339.74 and a completion date of September 16, 2022.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This is a delivery order for $1,298.80 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of 4565505380 - Clindamycin Phosphate 1% Foam 100GM, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $7,896.17 firm fixed price contract is for the delivery of 4565069605 - Clindamycin Phosphate 1% Foam 100GM. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued...
The Defense Logistics Agency awarded a $546.49 delivery order to Amerisourcebergen Drug Corporation for clindamycin phosphate 1% foam. As the prime contractor, Amerisourcebergen will supply 100 grams of the topical antibiotic to fulfill DLA requirements under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 23 to August 24, 2023. No subcontractors or set aside designations were identified. The...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,312,292 units of Clindamycin Phosphate 1% Foam, 50 grams. The total potential value of the order is $3,521.02, with a completion date of January 12, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,173.74 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% Foam, a topical antibiotic medication. The contract has a period of performance through November 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...